Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant Recipients

New England Journal of Medicine

Volumn 323, Issue 25, 1990, Pages 1723-1728

  Swinnen, Lode J ^b,c   Costanzo Nordin, Maria R ^a   Fisher, Susan G ^c   O'sullivan, E Jeanne ^b,c   Johnson, Maryl R ^b,c   Heroux, Alain L ^b,c   Dizikes, George J ^b,c   Pifarre, Roque ^b,c   Fisher, Richard I ^b,c  

^a Loyola University of Chicago ^*

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c HINES VA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY;

ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGE; POSTOPERATIVE COMPLICATIONS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 0025661946     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199012203232502     Document Type: Article

References (29)

1. Penn I. Lymphomas complicating organ transplantation. Transplant Proc 1983; 15: Suppl 1: 2790–7.
2. Nalesnik MA, Makowka L, Starzl TE. The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 1988; 25: 371–472.
3. Purtilo DT. Epstein–Barrvirus-induced oncogenesis in immune-deficient individuals. Lancet 1980; 1: 300–3.
4. Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphoma in 90 homosexual men: relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984; 311: 565–70.
5. Joncas JH, Russo P, Brochu P, et al. Epstein–Barr virus polymorphic B-cell lymphoma associated with leukemia and with congenital immunodeficiencies. J Clin Oncol 1990; 8: 378–84.
6. Ho M, Miller G, Atchison RW, et al. Epstein–Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis 1985; 152: 876–86.
7. Ho M, Jaffe R, Miller G, et al. The frequency of Epstein–Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988; 45: 719–27.
8. Young L, Alfieri C, Hennessy K, et al. Expression of Epstein–Barr virus transformation—associated genes in tissue of patients with EBV lymphoproliferative disease. N Engl J Med 1989; 321: 1080–5.
9. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 1981; 41: 4262–79.
10. Weintraub J, Warnke RA. Lymphoma in cardiac allotransplant recipients: clinical and histological features and immunological phenotype. Transplantation 1982; 33: 347–51.
11. Hanto DW, Frizzera G, Gajl-Peczalska KJ, et al. Epstein–Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 1982; 306: 913–8.
12. Cleary ML, Chao J, Warnke R, Sklar J. Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc Natl Acad Sci USA 1984; 81: 593–7.
13. Arnold A, Cossman J, Bakhshi A, Jaffe ES, Waldmann TA, Korsmeyer SJ. Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med 1983; 309: 1593–9.
14. Nalesnik MA, Jaffe RJ, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133: 173–92.
15. Hanto DW, Birkenbach M, Frizzera G, Gajl-Peczalska KJ, Simmons RL, Schubach WH. Confirmation of the heterogeneity of posttransplant Epstein–Barr virus-associated B cell proliferations by immunoglobulin gene rearrangement analyses. Transplantation 1989; 47: 458–64.
16. Cleary ML, Warnke R, Sklar J. Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients: clonal analysis based on immunoglobulin-gene rearrangements. N Engl J Med 1984; 310: 477–82.
17. O'Connell JB, Renlund DG, Bristow MR. Murine monoclonal CD3 antibody (OKT3) in cardiac transplantation: three year experience. Transplant Proc 1989; 21: Suppl 2: 31–3.
18. Efficacy of induction and non-induction immunosuppression in cardiac transplantation: a report of the Working Group of Transplant Cardiologists. J Heart Transplant 1990; 9: 61. abstract.
19. Barr ML, Seche LA, Smith CR, Rose EA. Anti-CD3 monoclonal antibody induction therapy: immunologic equivalency with triple drug therapy in heart transplantation. Circulation (in press).
20. Billingham ME. Some recent advances in cardiac pathology. Hum Pathol 1979; 10: 367–86.
21. Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–35.
22. Domenico DR, Dizikes GJ, Melnyk AR, Bird ML, Suarez CR, Schumacher HR. Pseudoleukemia in Down's syndrome: analysis of immunophenotype and gene rearrangement. Am J Clin Pathol 1989; 91: 709–14.
23. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1984; 1: 583–7.
24. Beveridge T, Krupp P, McKibbin C. Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy. Lancet 1984; 1: 788.
25. Witherspoon RP, Fisher LD, Schoch G, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989; 321: 784–9.
26. Shapiro RS, McClain K, Frizzera G, et al. Epstein–Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988; 71: 1234–43.
27. Randhawa PS, Yousem SA, Paradis IL, Dauber JA, Griffith BP, Locker J. The clinical spectrum, pathology, and clonal analysis of Epstein–Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol 1989; 92: 177–85.
28. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL. Epstein–Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 1985; 39: 461–72.
29. Armitage JM, Griffith BP, Hardesty RL, Kormos RL, Dummer JS. Lymphoproliferative disease in heart and lung transplant recipients: the University of Pittsburgh experience. J Heart Transplant 1990; 9: 60. abstract.